디앤디파마텍

Business Overview

D&D Pharmatech is a biopharmaceutical company specializing in developing innovative drugs for metabolic diseases, such as obesity and MASH (metabolic-associated steatohepatitis), and neurodegenerative disorders like Parkinson's and Alzheimer's, leveraging GLP-1-based peptide technology. The company's key pipelines include oral weight-loss medications and MASH treatments, with a business model focused on licensing and co-development with global partners. Additionally, it expands into areas such as PET biomarker development and alpha radiation-based cancer therapies through its subsidiaries.